Effects of antenatal dexamethasone on postnatal serum cortisol levels in late preterm infants

References

• Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12):1190–1198. doi: 10.1056/NEJMoa071453.
   PubMed Web of Science ®Google Scholar
• Kochukhova O, Fredriksson KY, Johansson M, et al. Antenatal steroids and neurodevelopment in 12-year-old children born extremely preterm. Acta Paediatr. 2022;111(2):314–322. doi: 10.1111/apa.16140.
   PubMed Web of Science ®Google Scholar
• Engle WA, Tomashek KM, Wallman C. Late-preterm" infants: a population at risk. Pediatrics. 2007;120(6):1390–1401. doi: 10.1542/peds.2007-2952.
   PubMed Web of Science ®Google Scholar
• McGoldrick E, Stewart F, Parker R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12: cd004454.
   PubMedGoogle Scholar
• Kitsommart R, Phatihattakorn C, Pornladnun P, et al. A prospective study of the severity of early respiratory distress in late preterms compared to term infants. J Matern Fetal Neonatal Med. 2016;29(2):207–212. doi: 10.3109/14767058.2014.992335.
   PubMed Web of Science ®Google Scholar
• Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374(14):1311–1320. doi: 10.1056/NEJMoa1516783.
   PubMed Web of Science ®Google Scholar
• Kearsey EOR, Been JV, Souter VL, et al. The impact of the antenatal late preterm steroids trial on the administration of antenatal corticosteroids. Am J Obstet Gynecol. 2022;227(2):280.e1–280.e15. doi: 10.1016/j.ajog.2022.03.037.
   PubMed Web of Science ®Google Scholar
• Committee Opinion. No713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130:e930–e102.
   Web of Science ®Google Scholar
• Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA. 1995;273:413–418.
   Google Scholar
• Dixon CL, Too G, Saade GR, et al. Past and present: a review of antenatal corticosteroids and recommendations for late preterm birth steroids. Am J Perinatol. 2018;35(13):1241–1250. doi: 10.1055/s-0038-1653944.
   PubMed Web of Science ®Google Scholar
• Kamath-Rayne BD, Rozance PJ, Goldenberg RL, et al. Antenatal corticosteroids beyond 34 weeks gestation: what do we do now? Am J Obstet Gynecol. 2016;215(4):423–430. doi: 10.1016/j.ajog.2016.06.023.
   PubMed Web of Science ®Google Scholar
• Haviv HR, Said J, Mol BW. The place of antenatal corticosteroids in late preterm and early term births. Semin Fetal Neonatal Med. 2019;24(1):37–42. doi: 10.1016/j.siny.2018.10.001.
   PubMed Web of Science ®Google Scholar
• Ninan K, Liyanage SK, Murphy KE, et al. Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis. JAMA Pediatr. 2022;176(6):e220483. doi: 10.1001/jamapediatrics.2022.0483.
   PubMed Web of Science ®Google Scholar
• Räikkönen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA. 2020;323(19):1924–1933. doi: 10.1001/jama.2020.3937.
   PubMed Web of Science ®Google Scholar
• Räikkönen K, Gissler M, Tapiainen T, et al. Associations between maternal antenatal corticosteroid treatment and psychological developmental and neurosensory disorders in children. JAMA Netw Open. 2022;5(8):e2228518. doi: 10.1001/jamanetworkopen.2022.28518.
   PubMed Web of Science ®Google Scholar
• Shanks AL, Grasch JL, Quinney SK, et al. Controversies in antenatal corticosteroids. Semin Fetal Neonatal Med. 2019;24(3):182–188. doi: 10.1016/j.siny.2019.05.002.
   PubMed Web of Science ®Google Scholar
• Wynne K, Rowe C, Delbridge M, et al. Antenatal corticosteroid administration for foetal lung maturation. F1000Res. 2020;9:219. doi: 10.12688/f1000research.20550.1.
   Google Scholar
• Schäffer L, Luzi F, Burkhardt T, et al. Antenatal betamethasone administration alters stress physiology in healthy neonates. Obstet Gynecol. 2009;113(5):1082–1088. doi: 10.1097/AOG.0b013e3181a1f0e6.
   PubMed Web of Science ®Google Scholar
• Waffarn F, Davis EP. Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations. Am J Obstet Gynecol. 2012;207(6):446–454. doi: 10.1016/j.ajog.2012.06.012.
   PubMed Web of Science ®Google Scholar
• Crowther CA, McKinlay CJ, Middleton P, et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2015;2015(7):Cd003935. doi: 10.1002/14651858.CD003935.pub4.
   PubMedGoogle Scholar
• McKinzie AH, Yang Z, Teal E, et al. Are newborn outcomes different for term babies who were exposed to antenatal corticosteroids? Am J Obstet Gynecol. 2021;225(5):536.e1–536.e7. doi: 10.1016/j.ajog.2021.04.251.
   PubMed Web of Science ®Google Scholar
• WHO ACTION Trials Collaborators. Antenatal dexamethasone for late preterm birth: a multi-Centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial. EClinicalMedicine. 2022;44:101285.
   Google Scholar
• Jobe AH, Milad MA, Peppard T, et al. Pharmacokinetics and pharmacodynamics of intramuscular and oral betamethasone and dexamethasone in reproductive age women in India. Clin Transl Sci. 2020;13(2):391–399. doi: 10.1111/cts.12724.
   PubMed Web of Science ®Google Scholar
• AlSaad D, Lindow S, Lee BH, et al. Maternal, fetal, and neonatal outcomes associated with long-term use of corticosteroids during pregnancy. Obstet Gynecol. 2019;21(2):117–125. doi: 10.1111/tog.12556.
   Google Scholar
• Williams MJ, Ramson JA, Brownfoot FC. Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth. Cochrane Database Syst Rev. 2022;8(8):Cd006764. doi: 10.1002/14651858.CD006764.pub4.
   PubMedGoogle Scholar
• Adamkin D. Clinical report-postnatal glucose homeostasis in late-term and preterm infants. Pediatrics. 2011;127(3):575–579. doi: 10.1542/peds.2010-3851.
   PubMed Web of Science ®Google Scholar
• Teramo K, Hallman M, Raivio KO. Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant. Pediatr Res. 1980;14(4 Pt 1):326–329. doi: 10.1203/00006450-198004000-00013.
   PubMed Web of Science ®Google Scholar
• Enver EO, Vatansever P, Guran O, et al. Adrenal steroids reference ranges in infancy determined by LC-MS/MS. Pediatr Res. 2022;92(1):265–274. doi: 10.1038/s41390-021-01739-5.
   PubMed Web of Science ®Google Scholar
• Antenatal dexamethasone for late preterm birth: a multi-Centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial. EClinicalMedicine. 2022;44:101285.
   PubMedGoogle Scholar
• Ben-David A, Zlatkin R, Bookstein-Peretz S, et al. Does antenatal steroids treatment in twin pregnancies prior to late preterm birth reduce neonatal morbidity? Evidence from a retrospective cohort study. Arch Gynecol Obstet. 2020;302(5):1121–1126. doi: 10.1007/s00404-020-05709-w.
   PubMed Web of Science ®Google Scholar
• Vieira LA, Kao Y-H, Tsevdos DS, et al. Late preterm antenatal corticosteroids in singleton and twin gestations: a retrospective cohort study. BMC Pregnancy Childbirth. 2022;22(1):904. doi: 10.1186/s12884-022-05262-1.
   PubMed Web of Science ®Google Scholar
• Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol. 1995;173(1):254–262. doi: 10.1016/0002-9378(95)90210-4.
   PubMed Web of Science ®Google Scholar
• Merrill JD, Ballard RA. Clinical use of antenatal corticosteroids: benefits and risks. Pediatr Rev. 2000;1(5):E91–8. doi: 10.1542/neo.1-5-e91.
   PubMedGoogle Scholar
• Banks BA, Cnaan A, Morgan MA, et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American thyrotropin-releasing hormone study group. Am J Obstet Gynecol. 1999;181(3):709–717. doi: 10.1016/s0002-9378(99)70517-x.
   PubMed Web of Science ®Google Scholar
• Karlsson R, Kallio J, Toppari J, et al. Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants. Horm Res. 2000;53(4):170–176. doi: 10.1159/000023563.
   PubMedGoogle Scholar
• Kiran P, Dutta S, Narang A, et al. Multiple courses of antenatal steroids. Indian J Pediatr. 2007;74(5):463–469. doi: 10.1007/s12098-007-0079-x.
   PubMed Web of Science ®Google Scholar
• Elliott CL, Read GF, Wallace EM. The pharmacokinetics of oral and intramuscular administration of dexamethasone in late pregnancy. Acta Obstet Gynecol Scand. 1996;75(3):213–216. doi: 10.3109/00016349609047089.
   PubMed Web of Science ®Google Scholar
• Egerman RS, Pierce W, Andersen RN, et al. A comparison of the bioavailability of oral and intramuscular dexamethasone in women in late pregnancy. Obstet Gynecol. 1997;89(2):276–280. doi: 10.1016/S0029-7844(96)00446-2.
   PubMed Web of Science ®Google Scholar
• Davis EP, Townsend EL, Gunnar MR, et al. Effects of prenatal betamethasone exposure on regulation of stress physiology in healthy premature infants. Psychoneuroendocrinology. 2004;29(8):1028–1036. doi: 10.1016/j.psyneuen.2003.10.005.
   PubMed Web of Science ®Google Scholar
• Gyamfi-Bannerman C, Jablonski KA, Blackwell SC, et al. Evaluation of hypoglycemia in neonates of women at risk for late preterm delivery: an antenatal late preterm steroids trial cohort study. Am J Perinatol. 2023;40(5):532–538. doi: 10.1055/s-0041-1729561.
   PubMedGoogle Scholar
• Battarbee AN, Sandoval GJ, Gyamfi-Bannerman C, et al. Mechanism of neonatal hypoglycemia after late preterm steroids: are fetal metabolic effects responsible? Am J Obstet Gynecol. 2022;227(2):347–349.e4. doi: 10.1016/j.ajog.2022.03.045.
   PubMed Web of Science ®Google Scholar